Global Blood Therapeutics (GBT) PT Lowered to $54 at Morgan Stanley
Tweet
Share
E-mail
Get Alerts GBT Hot Sheet
Price: $68.49 --0%
Rating Summary:
12 Buy, 15 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Rating Summary:
12 Buy, 15 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison lowered the price target on Global Blood Therapeutics (NASDAQ: GBT) to $54.00 (from $59.00) while maintaining a Equalweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aebi Schmidt Holding AG (AEBI) PT Raised to $17 at DA Davidson Following Q2 Results
- Nakamoto Holdings (NAKA) PT Lowered to $9 at B.Riley
- DeFi Technologies (DEFT) PT Lowered to $0.62 at B.Riley
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
